Huntsman Cancer Institute
Research facility
Location:
Salt Lake City, UT,
United States (USA) (US)
ISNI: 0000000404223447
ROR: https://ror.org/03v7tx966
Show on Map:
A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2 (2023)
Zanti M, O'Mahony DG, Parsons MT, Li H, Dennis J, Aittomäkkiki K, Andrulis IL, et al.
Journal article
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium (2021)
Morra A, Jung AY, Behrens S, Keeman R, Ahearn TU, Anton-Culver H, Arndt V, et al.
Journal article
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses (2021)
Kang EY, Cheasley D, LePage C, Wakefield MJ, da Cunha Torres M, Rowley S, Salazar C, et al.
Journal article
Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE) (2020)
Talhouk A, George J, Wang C, Budden T, Tan TZ, Chiu DS, Kommoss S, et al.
Journal article
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020)
Liu J, Prager-van der Smissen WJ, Collée JM, Bolla MK, Wang Q, Michailidou K, Dennis J, et al.
Journal article
Prognostic gene expression signature for high-grade serous ovarian cancer (2020)
Millstein J, Budden T, Goode EL, Anglesio MS, Talhouk A, Intermaggio MP, Leong HS, et al.
Journal article